Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | FDMT |
---|---|---|
09:32 ET | 25013 | 33.79 |
09:34 ET | 21044 | 33.64 |
09:36 ET | 4353 | 33.74 |
09:38 ET | 100 | 33.73 |
09:39 ET | 9796 | 33.71 |
09:41 ET | 3798 | 33.725 |
09:43 ET | 8749 | 33.495 |
09:45 ET | 29611 | 32.95 |
09:48 ET | 3431 | 33.02 |
09:50 ET | 5251 | 33 |
09:52 ET | 17288 | 33.04 |
09:54 ET | 9785 | 32.735 |
09:56 ET | 47126 | 32.8 |
09:57 ET | 20549 | 32.9 |
09:59 ET | 6262 | 32.5134 |
10:01 ET | 1755 | 32.555 |
10:03 ET | 11572 | 32.255 |
10:06 ET | 11162 | 31.55 |
10:08 ET | 24873 | 30.83 |
10:10 ET | 11564 | 31.13 |
10:12 ET | 17173 | 31.47 |
10:14 ET | 11186 | 31.395 |
10:15 ET | 17741 | 31.16 |
10:17 ET | 15322 | 31.4099 |
10:19 ET | 5841 | 31.64 |
10:21 ET | 8857 | 32.135 |
10:24 ET | 9557 | 32.53 |
10:26 ET | 1887 | 32.21 |
10:28 ET | 4799 | 32.02 |
10:30 ET | 8949 | 32.46 |
10:32 ET | 1472 | 32.46 |
10:33 ET | 6779 | 32.46 |
10:35 ET | 50394 | 32.52 |
10:37 ET | 1000 | 32.495 |
10:39 ET | 4167 | 32.88 |
10:42 ET | 6347 | 33.035 |
10:44 ET | 9590 | 32.695 |
10:46 ET | 11500 | 32.685 |
10:48 ET | 1402 | 32.5001 |
10:50 ET | 16655 | 32.85 |
10:51 ET | 5811 | 32.95 |
10:53 ET | 2900 | 32.95 |
10:55 ET | 11553 | 33.025 |
10:57 ET | 2818 | 32.91 |
11:00 ET | 903 | 32.73 |
11:02 ET | 600 | 32.72 |
11:04 ET | 4850 | 32.93 |
11:06 ET | 710 | 32.83 |
11:08 ET | 984 | 32.885 |
11:09 ET | 1125 | 32.98 |
11:11 ET | 4766 | 32.905 |
11:13 ET | 222 | 32.9212 |
11:15 ET | 831 | 32.81 |
11:18 ET | 1595 | 33.01 |
11:20 ET | 3734 | 33.095 |
11:22 ET | 13935 | 33.135 |
11:24 ET | 4220 | 33.29 |
11:27 ET | 45512 | 33.25 |
11:29 ET | 1859 | 33.25 |
11:31 ET | 3218 | 33.36 |
11:33 ET | 3605 | 33.275 |
11:36 ET | 4173 | 33.01 |
11:38 ET | 3936 | 32.81 |
11:40 ET | 1314 | 32.68 |
11:42 ET | 242 | 32.63 |
11:44 ET | 1070 | 32.4837 |
11:45 ET | 5565 | 32.34 |
11:47 ET | 512 | 32.425 |
11:49 ET | 5675 | 32.215 |
11:51 ET | 1000 | 32.0001 |
11:54 ET | 25720 | 32.22 |
11:56 ET | 2349 | 32.49 |
11:58 ET | 2350 | 32.63 |
12:00 ET | 2187 | 32.585 |
12:02 ET | 6651 | 32.7 |
12:03 ET | 4799 | 32.85 |
12:05 ET | 1300 | 32.71 |
12:07 ET | 100 | 32.55 |
12:09 ET | 1817 | 32.565 |
12:12 ET | 1082 | 32.555 |
12:14 ET | 700 | 32.55 |
12:16 ET | 2346 | 32.54 |
12:18 ET | 4925 | 32.37 |
12:20 ET | 1100 | 32.455 |
12:21 ET | 736 | 32.45 |
12:23 ET | 3444 | 32.46 |
12:25 ET | 100 | 32.43 |
12:27 ET | 6235 | 32.57 |
12:30 ET | 1119 | 32.61 |
12:32 ET | 4836 | 32.45 |
12:34 ET | 1773 | 32.455 |
12:36 ET | 4113 | 32.4 |
12:38 ET | 1400 | 32.28 |
12:39 ET | 3714 | 32.095 |
12:41 ET | 13527 | 32.16 |
12:43 ET | 10737 | 32.28 |
12:45 ET | 1213 | 32.365 |
12:48 ET | 146 | 32.365 |
12:50 ET | 605 | 32.29 |
12:52 ET | 455 | 32.21 |
12:54 ET | 705 | 32.18 |
12:56 ET | 1874 | 32.16 |
12:57 ET | 200 | 32.1672 |
12:59 ET | 1633 | 32.09 |
01:01 ET | 735 | 32.095 |
01:03 ET | 1400 | 32.19 |
01:06 ET | 400 | 32.175 |
01:08 ET | 100 | 32.18 |
01:10 ET | 2797 | 32.14 |
01:12 ET | 19636 | 32.1699 |
01:14 ET | 978 | 32.14 |
01:15 ET | 1800 | 32.075 |
01:17 ET | 703 | 32.08 |
01:19 ET | 1632 | 32.075 |
01:21 ET | 1305 | 32.12 |
01:24 ET | 1000 | 32.1 |
01:26 ET | 1778 | 32.12 |
01:28 ET | 5036 | 31.98 |
01:30 ET | 4511 | 32.01 |
01:32 ET | 3887 | 31.99 |
01:33 ET | 9137 | 31.98 |
01:35 ET | 6643 | 31.95 |
01:37 ET | 7326 | 31.91 |
01:39 ET | 7855 | 31.98 |
01:42 ET | 1100 | 32 |
01:44 ET | 1536 | 32.1 |
01:46 ET | 1944 | 31.86 |
01:48 ET | 6077 | 31.68 |
01:50 ET | 1200 | 31.345 |
01:51 ET | 2795 | 31.535 |
01:53 ET | 1136 | 31.495 |
01:55 ET | 4371 | 31.5 |
01:57 ET | 1861 | 31.52 |
02:00 ET | 6689 | 31.48 |
02:02 ET | 8158 | 31.53 |
02:04 ET | 33673 | 31.53 |
02:06 ET | 8958 | 31.27 |
02:08 ET | 5807 | 31.29 |
02:09 ET | 1981 | 31.21 |
02:11 ET | 15484 | 30.88 |
02:13 ET | 1139 | 30.885 |
02:15 ET | 5477 | 30.9 |
02:18 ET | 1332 | 30.96 |
02:20 ET | 8966 | 30.885 |
02:22 ET | 4201 | 30.94 |
02:24 ET | 5456 | 31.045 |
02:26 ET | 2114 | 31.07 |
02:27 ET | 8477 | 31.09 |
02:29 ET | 3763 | 31.31 |
02:31 ET | 1923 | 31.49 |
02:33 ET | 4351 | 31.82 |
02:36 ET | 967 | 31.83 |
02:38 ET | 6464 | 31.5301 |
02:40 ET | 2716 | 31.5 |
02:42 ET | 3729 | 31.49 |
02:44 ET | 2421 | 31.535 |
02:45 ET | 1958 | 31.65 |
02:47 ET | 4201 | 31.63 |
02:49 ET | 1141 | 31.755 |
02:51 ET | 3074 | 31.625 |
02:54 ET | 2222 | 31.78 |
02:56 ET | 2976 | 31.73 |
02:58 ET | 2841 | 31.9001 |
03:00 ET | 2621 | 32.14 |
03:02 ET | 100 | 32.16 |
03:03 ET | 2155 | 32.135 |
03:05 ET | 1493 | 32.02 |
03:07 ET | 647 | 32.04 |
03:09 ET | 2117 | 32.14 |
03:12 ET | 807 | 32.18 |
03:14 ET | 1832 | 32.4899 |
03:16 ET | 2143 | 32.19 |
03:18 ET | 1010 | 32.225 |
03:20 ET | 2016 | 31.99 |
03:21 ET | 2266 | 31.92 |
03:23 ET | 1895 | 31.83 |
03:25 ET | 1249 | 31.89 |
03:27 ET | 3537 | 31.9 |
03:30 ET | 5188 | 31.78 |
03:32 ET | 5093 | 31.765 |
03:34 ET | 15483 | 31.75 |
03:36 ET | 3672 | 31.805 |
03:38 ET | 2234 | 31.81 |
03:39 ET | 4130 | 31.83 |
03:41 ET | 7014 | 31.56 |
03:43 ET | 6682 | 31.48 |
03:45 ET | 7498 | 31.645 |
03:48 ET | 3547 | 31.775 |
03:50 ET | 2747 | 31.89 |
03:52 ET | 7061 | 31.96 |
03:54 ET | 6513 | 32.155 |
03:56 ET | 11387 | 32.025 |
03:57 ET | 13289 | 32.02 |
03:59 ET | 20837 | 31.86 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
4D Molecular Therapeutics Inc | 1.6B | -12.4x | --- |
Agios Pharmaceuticals Inc | 1.6B | -4.6x | --- |
Kura Oncology Inc | 1.6B | -10.2x | --- |
Disc Medicine Inc | 1.5B | -8.4x | --- |
Inhibrx Inc | 1.7B | -7.0x | --- |
Akero Therapeutics Inc | 1.7B | -8.9x | --- |
4D Molecular Therapeutics, Inc. is a clinical-stage genetic medicines company focused on unlocking the full potential of genetic medicines to treat diseases in ophthalmology and pulmonology. The Company has a portfolio of genetic medicine product candidates, with five product candidates in clinical trials in seven patient populations: 4D-150 for the treatment of wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME), 4D-710 for the treatment of cystic fibrosis lung disease (both in modulator ineligible and eligible populations), 4D-310 for the treatment of Fabry disease cardiomyopathy, 4D-125 for the treatment of X-linked retinitis pigmentosa (XLRP), and 4D-110 for the treatment of choroideremia. In addition, it has two product candidates in preclinical development: 4D-175 for geographic atrophy (GA) and 4D-725 for alpha-1 antitrypsin deficiency lung disease.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.6B |
---|---|
Revenue (TTM) | $20.7M |
Shares Outstanding | 49.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.58 |
Book Value | $7.15 |
P/E Ratio | -12.4x |
Price/Sales (TTM) | 76.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -544.65% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.